文献速递中医内科中医骨伤中药与中成药合理使用

青娥丸通过AGE/RAGE通路纠正糖尿病骨质疏松骨稳态失衡:网络药理学与多组学验证

Qing'e Pill rectifies bone homeostasis imbalance in diabetic osteoporosis via the AGE/RAGE pathway: A network pharmacology analysis and multi-omics validation.
PubMed 文献 · J Ethnopharmacol · 2025-04-15

本研究采用网络药理学结合实验室分析,探讨青娥丸治疗糖尿病骨质疏松(DOP)的机制。在DOP大鼠模型中,青娥丸可改善骨密度与微结构,体外实验显示其促进成骨与血管生成,并调控AGE/RAGE通路,发挥抗炎、降糖及抗骨质疏松作用。

要点

  • 青娥丸可能通过调控AGE/RAGE通路改善糖尿病骨质疏松的骨稳态。
  • 青娥丸在DOP大鼠中显示改善骨密度与骨微结构的作用。
  • 体外实验提示青娥丸具有促进成骨与血管生成的潜力。

核心结论

  • 青娥丸通过AGE/RAGE信号通路增强成骨与血管生成,发挥抗炎、降糖及抗骨质疏松作用,支持其临床应用于糖尿病骨质疏松的潜力。

研究设计与样本

  • 研究利用GeneCards、TTD、OMIM数据库识别DOP相关基因靶点,并通过HPLC分析青娥丸的活性成分。
  • 在DOP大鼠模型中监测血糖水平,采用Micro-CT成像和组织学染色评估治疗效果。
  • 体外实验验证青娥丸促进骨形成的能力,并通过划痕、迁移和管形成实验评估其血管生成潜力。

主要发现

  • 青娥丸在体外刺激成骨和血管生成,调控AGE/RAGE信号通路,并促进抗炎性成骨。
  • Micro-CT分析显示青娥丸治疗后骨密度和微结构显著改善。

临床怎么用

  • 青娥丸可能作为糖尿病骨质疏松的潜在治疗选择,其机制涉及AGE/RAGE通路调控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Diabetic osteoporosis (DOP), a metabolic disorder arising from diabetes mellitus, results in a hyperglycemic state that impairs bone microstructure, strength, and quality, thereby increasing the risk of fractures and complicating treatment and rehabilitation. Qing'e Pill(QEP), first recorded in the Song Dynasty's Heji Ju Fang, is renowned as an effective formula for tonifying the kidneys and strengthening bones. Its potential therapeutic mechanisms for treating DOP remain to be explored. AIM OF THE STUDY: This study aimed to elucidate the therapeutic mechanism of QEP, a Chinese herbal medicine compound, in the treatment of DOP by integrating network pharmacology and laboratory analyses. MATERIALS AND METHODS: Gene targets associated with DOP were identified utilizing gene databases (GeneCards, TTD, OMIM). The active ingredients of QEP were characterized via HPLC analysis. The therapeutic potential of QEP was assessed in a rat model of DOP by monitoring blood glucose levels, employing Micro-CT imaging, and conducting histological staining. In vitro experiments were performed to confirm QEP's ability to promote bone formation. Additionally, its angiogenic potential was evaluated using scratch, migration, and tube formation assays. RESULTS: QEP was observed to stimulate osteogenesis and angiogenesis in vitro, modulate the AGE/RAGE signaling pathway, and foster anti-inflammatory osteogenesis. Micro-CT analysis demonstrated significant enhancements in bone density and microstructure following QEP treatment. CONCLUSION: QEP enhance osteogenesis and angiogenesis via the AGE/RAGE signaling pathway, offering anti-inflammatory, hypoglycemic, and anti-osteoporotic effects. These results support the potential clinical application of QEP in managing diabetic osteoporosis.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Yang Y, Chen Y, et al. Qing'e Pill rectifies bone homeostasis imbalance in diabetic osteoporosis via the AGE/RAGE pathway: A network pharmacology analysis and multi-omics validation. J Ethnopharmacol. 2025. PMID: 40245968. doi:10.1016/j.jep.2025.119816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。